INSTRUCTIONS
Beingfully informed about your condition and treatment will help you decide whether to undergo treatment with botulinum type A (BTA This disclosure is not meant to alarm you; it is simply an effort to better inform you so that you may give or withhold your consent for this It treatment.is important that you read this information carefully and completely. Please sign the consent for this procedure proposed by your healthcare provider.
INTRODUCTION
Clostridium botulinum bacteria produce a class of chemical compounds known as "toxins." The BTA is processed and purified to produce a sterileproduct suitable for specific therapeutic use. Once the diluted toxin is injected, it produces a temporary paralysis (chemodenervation) ofby preventing the transmission of nerve impulses to the muscle. The duration of muscle paralysis generally lasts for approximately muscle three months.BTA has been used to treat certain conditions involving crossed eyes (strabismus), eyelid spasm (blepharospasm), and motor disorders of the facial nerve (VII cranial nerve It has been used in other "off-label uses for the treatment of facial wrinkles and neck bands caused by specific muscle groups. Certain spastic muscle disorders with the neck and colorectal area have also been treated with this agent. BTA injections are customized for every patient, depending on his or her particular needs. These can be performed in areas involving the eyelid region, forehead, and neck. BTA cannot stop the process of aging. It can, however, temporarily diminish the look of wrinkles caused by muscle groups.
ALTERNATIVE TREATMENTS
Alternative forms of management including not treating the skin wrinkles by any means. Improvement of the skin wrinkles may be accomplished by other treatments or alternative types of surgery such as a blepharoplasty, face or brow lift when indicated. Other forms of eyelid surgery may be needed should you have intrinsic disorders affecting the function of the eyelid, such as drooping eyelids from muscle problems (eyelid ptosis) or looseness between the eyelid and eyeball (ectropion Minor skin wrinkling may be improved throughchemical skinpeels, lasers, injection of filling material, or skin treatments. Risks and potential complications are associated with alternative forms of medical or surgical treatment.
RISK OF BOTULINUM TOXIN A INJECTIONS
Every procedure involves a certain amount of risk, and it is important that you understand the risks involved. An individual's choice to thisprocedure is based on the comparison of the risk to potential benefit. Although the majority of patients do not experience the undergo following complications, you should discuss each of them with your provider to make sure you understand the risks, potential complications, and consequences of BTA injections.
BLEEDING
It is possible,though unusual, to have a bleeding episode from a BTA injection. Bruising in soft tissues may occur. Serious bleeding around theeyeball during deeper BTA injections for crossed eyes (strabismus) has occurred. Should you develop post-injection bleeding, it may require emergency treatment or surgery. Doaspirin or anti-inflammatory medications for two days before BTA injections, as this may contribute to a greater risk of a nottake bleeding problem.
DAMAGE TO DEEPER STRUCTURES
structures such as nerves, blood vessels, and the eyeball may be damaged during the course of injection. Injury to deep structures may Deeper be temporary or permanent.
CORNEAL EXPOSURE PROBLEM
Some patients experience difficulties closing their eyelids after BTA injections, and problems may occur in the cornea due to dryness. Should this rare complication occur, additional treatments, protective eye drops, contact lenses, or surgery may be necessary.
DRY EYE PROBLEMS
Individuals who normally have dry eyes may be advised to use special caution in considering BTA injections around the eyelid region.
MIGRATION OF BTA
BTA may migrate from its original injection site to other areas and produce temporary paralysis of other muscle groups and other unintended effects.